InvestorsHub Logo
Post# of 252478
Next 10
Followers 12
Posts 648
Boards Moderated 0
Alias Born 12/20/2014

Re: DewDiligence post# 200721

Tuesday, 04/12/2016 5:35:38 AM

Tuesday, April 12, 2016 5:35:38 AM

Post# of 252478
ALNY has also a program for TTR (Transthyretin amyloidosis) target. It is currently in PhII. not sure which approach is better (RNAi vs CRISPR)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.